MacroGenics Inc.

MacroGenics Inc. is a clinical‑stage biopharma focused on antibody‑based oncology therapeutics. Its pipeline features ADCs, bispecifics, and T‑cell engagers in Phase 1–2 trials, partnered with Incyte, Gilead and TerSera for accelerated development.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Biotechnology Research

Employees: 341
HQ: Rockville

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
MGNX	MacroGenics Inc. Cap: 0.1B	EQUITY	NMS	USD	US5560991094	Active	📈